Prader-Willi syndrome (PWS) is a multisystemic complex genetic disorder.
PWS is relatively common with an estimated prevalence worldwide in the range of 1 in 10,000 to 30,000 individuals
Prader-Willi syndrome is due to absence of paternally expressed imprinted genes at 15q11.2-q13.
PWS was first described by Prader et al. in 1956 and it is the first recognized disorder related to genomic imprinting in humans.
PWS affects males and females with equal frequency and affects all races and ethnicities
Prader-Willi syndrome (PWS) is a genetic disorder that affects approximately 1 in 10,000-15,000 births. It results from a deletion or defect on chromosome 15 that causes specific genes to be inactive. Common features include low muscle tone, an insatiable appetite leading to obesity, developmental delays, and behavioral problems. Research has focused on understanding the causes of hypotonia and hyperphagia. While growth hormone treatment has led to benefits, the key genes responsible for features of PWS have not been identified, preventing targeted treatments. Identifying the causes of PWS could provide insights into other conditions like obesity and hypothalamic disorders.
Prader-Willi syndrome is a genetic disorder caused by abnormalities on chromosome 15 that results in problems with weight control and behavior. It is characterized by low muscle tone, short stature, cognitive disabilities, and an insatiable appetite that can lead to morbid obesity if not controlled. Treatment requires strict dietary management, behavioral therapy, and lifestyle modifications to address excessive eating and weight gain.
This case study describes the nutritional management of a 20-month-old boy diagnosed with Prader-Willi syndrome. Prader-Willi syndrome is a genetic disorder characterized by low muscle tone, difficulty feeding, and hyperphagia leading to obesity. The boy exhibited several common signs at birth and was tube fed until age 2 months. Currently, he requires calorie-restricted meals and snacks to manage his weight. His care involves multiple specialists and monitoring of growth, labs, and dietary compliance to support his nutritional needs and development.
Cri du Chat syndrome is a genetic disorder caused by a deletion on the short arm of chromosome 5. It is a non-hereditary disorder that occurs randomly during egg or sperm development in about 1 in 20,000 to 50,000 births. Symptoms include a cat-like cry due to larynx abnormalities, small size, distinctive facial features, and intellectual disabilities. While there is no cure, symptoms can be treated and life expectancy is normal without major organ defects.
This presentation covers topics such as history, prevalence, genetics, diagnosis and treatment for Angelman Syndrome (AS). With more emphasis on the genetics, this presentation will explain how maternal 15q deletion and/or paternal disomy leads to the "puppet-like" features which are exclusive for AS. Hope you will get enough information from the slides about AS. (This is a presentation that was done with the help of my classmate Sindhu J. R., initially for her class presentation.)
Fragile X syndrome is a genetic disorder and the most common inherited form of intellectual disability. It is caused by a mutation on the X chromosome that results in failure to produce a protein called FMRP. Without this protein, synaptic connections in the brain are abnormal. Fragile X syndrome symptoms can include cognitive impairment, behavioral and learning challenges, and various physical characteristics. While there is no cure, treatment aims to manage symptoms through educational support, therapies, and medications. Research continues on developing targeted drug therapies to treat the underlying condition.
Patau Syndrome, also known as Trisomy 13, is a genetic disorder caused by the presence of an extra copy of chromosome 13 or the improper placement of chromosome 13. It results in severe physical and mental abnormalities such as heart defects, unusual facial features, small head size, missing or small eyes, extra fingers and toes, and spinal defects. Diagnosis is typically made through ultrasounds, x-rays, MRI, CT scans, or chromosome studies. Treatments focus on addressing specific physical problems, though many infants have difficulties surviving beyond the first few weeks due to neurological or heart issues.
Prader-Willi syndrome (PWS) is a multisystemic complex genetic disorder.
PWS is relatively common with an estimated prevalence worldwide in the range of 1 in 10,000 to 30,000 individuals
Prader-Willi syndrome is due to absence of paternally expressed imprinted genes at 15q11.2-q13.
PWS was first described by Prader et al. in 1956 and it is the first recognized disorder related to genomic imprinting in humans.
PWS affects males and females with equal frequency and affects all races and ethnicities
Prader-Willi syndrome (PWS) is a genetic disorder that affects approximately 1 in 10,000-15,000 births. It results from a deletion or defect on chromosome 15 that causes specific genes to be inactive. Common features include low muscle tone, an insatiable appetite leading to obesity, developmental delays, and behavioral problems. Research has focused on understanding the causes of hypotonia and hyperphagia. While growth hormone treatment has led to benefits, the key genes responsible for features of PWS have not been identified, preventing targeted treatments. Identifying the causes of PWS could provide insights into other conditions like obesity and hypothalamic disorders.
Prader-Willi syndrome is a genetic disorder caused by abnormalities on chromosome 15 that results in problems with weight control and behavior. It is characterized by low muscle tone, short stature, cognitive disabilities, and an insatiable appetite that can lead to morbid obesity if not controlled. Treatment requires strict dietary management, behavioral therapy, and lifestyle modifications to address excessive eating and weight gain.
This case study describes the nutritional management of a 20-month-old boy diagnosed with Prader-Willi syndrome. Prader-Willi syndrome is a genetic disorder characterized by low muscle tone, difficulty feeding, and hyperphagia leading to obesity. The boy exhibited several common signs at birth and was tube fed until age 2 months. Currently, he requires calorie-restricted meals and snacks to manage his weight. His care involves multiple specialists and monitoring of growth, labs, and dietary compliance to support his nutritional needs and development.
Cri du Chat syndrome is a genetic disorder caused by a deletion on the short arm of chromosome 5. It is a non-hereditary disorder that occurs randomly during egg or sperm development in about 1 in 20,000 to 50,000 births. Symptoms include a cat-like cry due to larynx abnormalities, small size, distinctive facial features, and intellectual disabilities. While there is no cure, symptoms can be treated and life expectancy is normal without major organ defects.
This presentation covers topics such as history, prevalence, genetics, diagnosis and treatment for Angelman Syndrome (AS). With more emphasis on the genetics, this presentation will explain how maternal 15q deletion and/or paternal disomy leads to the "puppet-like" features which are exclusive for AS. Hope you will get enough information from the slides about AS. (This is a presentation that was done with the help of my classmate Sindhu J. R., initially for her class presentation.)
Fragile X syndrome is a genetic disorder and the most common inherited form of intellectual disability. It is caused by a mutation on the X chromosome that results in failure to produce a protein called FMRP. Without this protein, synaptic connections in the brain are abnormal. Fragile X syndrome symptoms can include cognitive impairment, behavioral and learning challenges, and various physical characteristics. While there is no cure, treatment aims to manage symptoms through educational support, therapies, and medications. Research continues on developing targeted drug therapies to treat the underlying condition.
Patau Syndrome, also known as Trisomy 13, is a genetic disorder caused by the presence of an extra copy of chromosome 13 or the improper placement of chromosome 13. It results in severe physical and mental abnormalities such as heart defects, unusual facial features, small head size, missing or small eyes, extra fingers and toes, and spinal defects. Diagnosis is typically made through ultrasounds, x-rays, MRI, CT scans, or chromosome studies. Treatments focus on addressing specific physical problems, though many infants have difficulties surviving beyond the first few weeks due to neurological or heart issues.
Achondroplasia is a type of dwarfism caused by a mutation in the FGFR3 gene, which regulates bone growth. It results in short limbs, an enlarged head, and limited joint movement. While it cannot be cured, treatment focuses on monitoring health, preventing complications, and alleviating symptoms like back pain and sleep apnea. People with achondroplasia can live normal lives through adaptations and with support from family and community.
This document discusses Down syndrome, including its causes, features in newborns, diagnosis, and management. Down syndrome results from extra genetic material from chromosome 21, which can occur through trisomy 21, mosaicism, or translocation. Affected newborns commonly have hypotonia, slanted eyes, and other physical signs. Prenatal screening and testing can detect Down syndrome. Early intervention aims to support development and address any health issues.
Angelman Syndrome is a genetic disorder characterized by developmental delay, neurological problems, frequent laughter and smiling, and absence of speech. It is caused by the absence or deletion of the UBE3A gene on chromosome 15, which regulates a protein important for neural development. While there is no known cure, early diagnosis and therapies can help improve quality of life by managing symptoms like seizures, providing physical and communication support.
Fragile X Syndrome (FXS) is caused by a mutation on the X chromosome involving expansion of the CGG repeat in the FMR1 gene. This leads to hypermethylation and reduced production of the Fragile X Mental Retardation Protein (FMRP). Lack of FMRP results in excessive mGluR signaling and protein synthesis at synapses. FXS is characterized by intellectual disability, autism-like behaviors, and various physical features. Testing involves genetic tests like PCR and Southern blot. Treatment focuses on mGluR antagonists to reduce excessive signaling, with several drugs in clinical trials showing promise based on preclinical findings in animal models of FXS.
This document discusses Alagille syndrome (ALGS), a multisystem genetic disorder caused by mutations in the JAG1 gene. It notes that ALGS affects the liver, heart, kidneys, skeletal system, and facial features. Methods for studying the JAG1 gene such as DNA extraction, DHPLC, RT-PCR, and sequencing are also summarized. Several figures show examples of mutations identified through these techniques, including a splicing mutation and exon deletion. The document reviews findings from other studies on the clinical effects of different JAG1 mutations.
Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. It causes lifelong intellectual disability and developmental delays. There are three main types of Down syndrome - Trisomy 21, Mosaic Down syndrome, and Translocation Down syndrome. Trisomy 21 accounts for 95% of cases and is caused by abnormal cell division during conception. While Down syndrome cannot be prevented or cured, early intervention programs can help children with Down syndrome develop important skills and abilities. Individuals with Down syndrome also often face increased health risks such as heart defects and dementia. However, with medical advances, the average life expectancy for people with Down syndrome is now over 50 years.
Patau syndrome, also known as trisomy 13, is a rare genetic disorder caused by the presence of an extra copy of chromosome 13. It often results in miscarriage, stillbirth, or death in the first year of life. Babies born with Patau syndrome experience slow growth and development with low birth weight. They typically have several serious medical problems affecting the brain, heart, kidneys and other organs. While there is no cure, treatment aims to address symptoms through surgery, feeding tubes, and therapies. Most children with Patau syndrome do not survive past one year of age.
Single gene disorders with non-classic inheritance patterns can be caused by trinucleotide repeat mutations, mutations in mitochondrial genes, genomic imprinting, or gonadal mosaicism. Trinucleotide repeat disorders are caused by the expansion of repeats, usually containing G and C, which can impair gene function. Examples include fragile X syndrome and Huntington disease. Mitochondrial gene mutations are maternally inherited and affect tissues with high energy demands. Genomic imprinting involves parent-of-origin specific gene silencing through DNA methylation. Diseases caused include Prader-Willi and Angelman syndromes, which involve deletions on chromosome 15 but present differently depending on whether the paternal or maternal allele is deleted.
John Langdon Down was a British physician who first described Down syndrome in 1866 and recognized it as a distinct medical condition; he proposed that it results from reversion to ancestral traits seen in other races. Down syndrome, also known as trisomy 21, occurs when there is an extra chromosome 21 present and results in cognitive impairment and physical characteristics including a flat facial profile, upward slanting eyes, and a short neck. The risk of Down syndrome increases with maternal age and proper prenatal screening and testing can help diagnose the condition before birth.
The document discusses disorders of sexual differentiation (DSD). It begins by describing typical embryonic development of male and female genitalia. Common causes of DSD are then discussed, including congenital adrenal hyperplasia (CAH), which can cause virilization of 46,XX individuals. Other conditions mentioned are ovotesticular DSD, complete and partial androgen insensitivity syndrome, 5-alpha reductase deficiency, persistent Müllerian duct syndrome, mixed gonadal dysgenesis, and complete gonadal dysgenesis. The roles of various genes in sexual development are also summarized. Clinical features, investigations, and management considerations are provided for different DSD conditions.
Angelman syndrome is a neurogenetic disorder characterized by developmental delays, lack of speech, seizures, and a happy demeanor. It is caused by a genetic mutation or deletion on chromosome 15 that disrupts the UBE3A gene. The syndrome was first described in 1965 by British pediatrician Harry Angelman and affects an estimated 12,000 to 20,000 people worldwide. While there is no cure, treatment aims to manage symptoms through educational and behavioral therapies.
Beckwith-Wiedemann syndrome is a genetic disorder associated with abnormal growth and increased risk of certain childhood cancers. It is caused by changes in chromosome 11p15, including uniparental disomy where both copies of chromosome 11 are inherited from only the father. This disrupts the normal patterns of gene expression and imprinting of genes in this region like IGF2 and CDKN1C. Affected individuals experience overgrowth and risks for tumors like Wilms tumor. While most cases are sporadic, some families show dominant inheritance. Treatment focuses on managing hypoglycemia and cancer screening.
Multifactorial disorders are caused by multiple genes interacting with environmental factors, with each factor making a small contribution. Common multifactorial disorders include asthma, autoimmune diseases, cancers, cardiovascular diseases, diabetes, and mood disorders. The risk of developing a multifactorial disorder is influenced by family history and other genetic and environmental risk factors. Treatment depends on the specific disorder but may include controlling environmental triggers, medication, and lifestyle changes.
Wilson's Disease is an autosomal recessive genetic disorder that causes copper to accumulate in the liver and other organs. It is caused by mutations in the ATP7B gene which encodes a copper-transporting ATPase. Left untreated, it can cause liver disease and neurological symptoms. The document discusses the history, signs and symptoms, investigations, treatment and management of Wilson's Disease including chelation therapy and dietary modifications to remove excess copper from the body.
Androgen Insensitivity Syndrome (AIS) is caused by mutations in the androgen receptor gene located on the X chromosome. There are three main types - complete AIS, partial AIS, and mild AIS - which vary in their phenotypic expression. Treatment depends on the type of AIS and may include gonadectomy, hormone replacement therapy, and counseling. Two case studies presented a family pedigree analysis showing phenotypic variation between individuals with the same mutation, and a patient with partial AIS who responded well to high dose testosterone therapy despite having a mutation in the androgen receptor binding domain.
Progeria (HGPS), also known as Hutchinson-Gilford syndrome, is a progressive genetic disorder that causes children to age rapidly, beginning in their first two years.
Patau syndrome, also known as trisomy 13, is a rare genetic disorder caused by the presence of an extra chromosome 13. It affects about 1 in 12,000 live births and causes severe intellectual and physical disabilities. Common signs include microcephaly, eye abnormalities, cleft palate, extra fingers or toes, and heart defects. While there is no cure, surgery can address some physical defects, though over 80% of infants with Patau syndrome do not survive past their first year.
Lysosomal storage disorders are a group of inherited metabolic diseases caused by deficiencies of lysosomal enzymes. This results in the accumulation of substrates in the lysosomes which causes cellular dysfunction. Some examples discussed include Gaucher disease, Tay-Sachs disease, Niemann-Pick disease, and Fabry disease. The document provides an overview of the causes and characteristics of these lysosomal storage disorders.
Down Syndrome, also known as trisomy 21, is a genetic disorder caused by the presence of a third copy of chromosome 21. It is the most common chromosome abnormality in humans, occurring in about 1 in 699 births in the US. Down Syndrome can be broken into three main types - trisomy 21 which accounts for 95% of cases, translocation Down Syndrome which is 3-4% of cases, and mosaic Down Syndrome which is less than 1% of cases. Physical features include stunted growth, slanted eyes, low-set ears, flattened nose, smaller teeth and shortened hands. Individuals with Down Syndrome often have intellectual disabilities ranging from mild to moderate and may experience delays in speech, motor skills,
The document provides information on various types of genetic disorders caused by chromosomal anomalies. It begins with definitions of key terms like aneuploidy, trisomy, monosomy, and discusses numerical and structural chromosomal anomalies. It then describes specific disorders in more detail, including Down syndrome, Edward syndrome, Patau syndrome, Turner syndrome, Klinefelter syndrome, Fragile X syndrome, Cri-Du-Chat syndrome, Wolf-Hirschhorn syndrome, Jacobsen syndrome, and Prader-Willi syndrome. It also discusses uniparental disomy and related disorders. In summary, the document defines genetic terminology and provides an overview of several important chromosomal anomalies and their associated genetic disorders
- NUTOGURT is a new frozen yogurt product made from a blend of low-fat yogurt and a milky extract of tigernut tubers. It is designed to be a low-fat alternative to ice cream while providing probiotic benefits.
- Tigernuts are a sedge family crop that are high in energy, minerals, vitamins and fiber. They are commonly used to make a milky beverage in Spain and Nigeria.
- NUTOGURT targets many customer groups due to its expected health benefits such as balancing stress levels, soft skin, improved digestion, reduced risk of colon cancer and heart disease, and being suitable for diabetics, the health conscious, and those with dairy
Achondroplasia is a type of dwarfism caused by a mutation in the FGFR3 gene, which regulates bone growth. It results in short limbs, an enlarged head, and limited joint movement. While it cannot be cured, treatment focuses on monitoring health, preventing complications, and alleviating symptoms like back pain and sleep apnea. People with achondroplasia can live normal lives through adaptations and with support from family and community.
This document discusses Down syndrome, including its causes, features in newborns, diagnosis, and management. Down syndrome results from extra genetic material from chromosome 21, which can occur through trisomy 21, mosaicism, or translocation. Affected newborns commonly have hypotonia, slanted eyes, and other physical signs. Prenatal screening and testing can detect Down syndrome. Early intervention aims to support development and address any health issues.
Angelman Syndrome is a genetic disorder characterized by developmental delay, neurological problems, frequent laughter and smiling, and absence of speech. It is caused by the absence or deletion of the UBE3A gene on chromosome 15, which regulates a protein important for neural development. While there is no known cure, early diagnosis and therapies can help improve quality of life by managing symptoms like seizures, providing physical and communication support.
Fragile X Syndrome (FXS) is caused by a mutation on the X chromosome involving expansion of the CGG repeat in the FMR1 gene. This leads to hypermethylation and reduced production of the Fragile X Mental Retardation Protein (FMRP). Lack of FMRP results in excessive mGluR signaling and protein synthesis at synapses. FXS is characterized by intellectual disability, autism-like behaviors, and various physical features. Testing involves genetic tests like PCR and Southern blot. Treatment focuses on mGluR antagonists to reduce excessive signaling, with several drugs in clinical trials showing promise based on preclinical findings in animal models of FXS.
This document discusses Alagille syndrome (ALGS), a multisystem genetic disorder caused by mutations in the JAG1 gene. It notes that ALGS affects the liver, heart, kidneys, skeletal system, and facial features. Methods for studying the JAG1 gene such as DNA extraction, DHPLC, RT-PCR, and sequencing are also summarized. Several figures show examples of mutations identified through these techniques, including a splicing mutation and exon deletion. The document reviews findings from other studies on the clinical effects of different JAG1 mutations.
Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. It causes lifelong intellectual disability and developmental delays. There are three main types of Down syndrome - Trisomy 21, Mosaic Down syndrome, and Translocation Down syndrome. Trisomy 21 accounts for 95% of cases and is caused by abnormal cell division during conception. While Down syndrome cannot be prevented or cured, early intervention programs can help children with Down syndrome develop important skills and abilities. Individuals with Down syndrome also often face increased health risks such as heart defects and dementia. However, with medical advances, the average life expectancy for people with Down syndrome is now over 50 years.
Patau syndrome, also known as trisomy 13, is a rare genetic disorder caused by the presence of an extra copy of chromosome 13. It often results in miscarriage, stillbirth, or death in the first year of life. Babies born with Patau syndrome experience slow growth and development with low birth weight. They typically have several serious medical problems affecting the brain, heart, kidneys and other organs. While there is no cure, treatment aims to address symptoms through surgery, feeding tubes, and therapies. Most children with Patau syndrome do not survive past one year of age.
Single gene disorders with non-classic inheritance patterns can be caused by trinucleotide repeat mutations, mutations in mitochondrial genes, genomic imprinting, or gonadal mosaicism. Trinucleotide repeat disorders are caused by the expansion of repeats, usually containing G and C, which can impair gene function. Examples include fragile X syndrome and Huntington disease. Mitochondrial gene mutations are maternally inherited and affect tissues with high energy demands. Genomic imprinting involves parent-of-origin specific gene silencing through DNA methylation. Diseases caused include Prader-Willi and Angelman syndromes, which involve deletions on chromosome 15 but present differently depending on whether the paternal or maternal allele is deleted.
John Langdon Down was a British physician who first described Down syndrome in 1866 and recognized it as a distinct medical condition; he proposed that it results from reversion to ancestral traits seen in other races. Down syndrome, also known as trisomy 21, occurs when there is an extra chromosome 21 present and results in cognitive impairment and physical characteristics including a flat facial profile, upward slanting eyes, and a short neck. The risk of Down syndrome increases with maternal age and proper prenatal screening and testing can help diagnose the condition before birth.
The document discusses disorders of sexual differentiation (DSD). It begins by describing typical embryonic development of male and female genitalia. Common causes of DSD are then discussed, including congenital adrenal hyperplasia (CAH), which can cause virilization of 46,XX individuals. Other conditions mentioned are ovotesticular DSD, complete and partial androgen insensitivity syndrome, 5-alpha reductase deficiency, persistent Müllerian duct syndrome, mixed gonadal dysgenesis, and complete gonadal dysgenesis. The roles of various genes in sexual development are also summarized. Clinical features, investigations, and management considerations are provided for different DSD conditions.
Angelman syndrome is a neurogenetic disorder characterized by developmental delays, lack of speech, seizures, and a happy demeanor. It is caused by a genetic mutation or deletion on chromosome 15 that disrupts the UBE3A gene. The syndrome was first described in 1965 by British pediatrician Harry Angelman and affects an estimated 12,000 to 20,000 people worldwide. While there is no cure, treatment aims to manage symptoms through educational and behavioral therapies.
Beckwith-Wiedemann syndrome is a genetic disorder associated with abnormal growth and increased risk of certain childhood cancers. It is caused by changes in chromosome 11p15, including uniparental disomy where both copies of chromosome 11 are inherited from only the father. This disrupts the normal patterns of gene expression and imprinting of genes in this region like IGF2 and CDKN1C. Affected individuals experience overgrowth and risks for tumors like Wilms tumor. While most cases are sporadic, some families show dominant inheritance. Treatment focuses on managing hypoglycemia and cancer screening.
Multifactorial disorders are caused by multiple genes interacting with environmental factors, with each factor making a small contribution. Common multifactorial disorders include asthma, autoimmune diseases, cancers, cardiovascular diseases, diabetes, and mood disorders. The risk of developing a multifactorial disorder is influenced by family history and other genetic and environmental risk factors. Treatment depends on the specific disorder but may include controlling environmental triggers, medication, and lifestyle changes.
Wilson's Disease is an autosomal recessive genetic disorder that causes copper to accumulate in the liver and other organs. It is caused by mutations in the ATP7B gene which encodes a copper-transporting ATPase. Left untreated, it can cause liver disease and neurological symptoms. The document discusses the history, signs and symptoms, investigations, treatment and management of Wilson's Disease including chelation therapy and dietary modifications to remove excess copper from the body.
Androgen Insensitivity Syndrome (AIS) is caused by mutations in the androgen receptor gene located on the X chromosome. There are three main types - complete AIS, partial AIS, and mild AIS - which vary in their phenotypic expression. Treatment depends on the type of AIS and may include gonadectomy, hormone replacement therapy, and counseling. Two case studies presented a family pedigree analysis showing phenotypic variation between individuals with the same mutation, and a patient with partial AIS who responded well to high dose testosterone therapy despite having a mutation in the androgen receptor binding domain.
Progeria (HGPS), also known as Hutchinson-Gilford syndrome, is a progressive genetic disorder that causes children to age rapidly, beginning in their first two years.
Patau syndrome, also known as trisomy 13, is a rare genetic disorder caused by the presence of an extra chromosome 13. It affects about 1 in 12,000 live births and causes severe intellectual and physical disabilities. Common signs include microcephaly, eye abnormalities, cleft palate, extra fingers or toes, and heart defects. While there is no cure, surgery can address some physical defects, though over 80% of infants with Patau syndrome do not survive past their first year.
Lysosomal storage disorders are a group of inherited metabolic diseases caused by deficiencies of lysosomal enzymes. This results in the accumulation of substrates in the lysosomes which causes cellular dysfunction. Some examples discussed include Gaucher disease, Tay-Sachs disease, Niemann-Pick disease, and Fabry disease. The document provides an overview of the causes and characteristics of these lysosomal storage disorders.
Down Syndrome, also known as trisomy 21, is a genetic disorder caused by the presence of a third copy of chromosome 21. It is the most common chromosome abnormality in humans, occurring in about 1 in 699 births in the US. Down Syndrome can be broken into three main types - trisomy 21 which accounts for 95% of cases, translocation Down Syndrome which is 3-4% of cases, and mosaic Down Syndrome which is less than 1% of cases. Physical features include stunted growth, slanted eyes, low-set ears, flattened nose, smaller teeth and shortened hands. Individuals with Down Syndrome often have intellectual disabilities ranging from mild to moderate and may experience delays in speech, motor skills,
The document provides information on various types of genetic disorders caused by chromosomal anomalies. It begins with definitions of key terms like aneuploidy, trisomy, monosomy, and discusses numerical and structural chromosomal anomalies. It then describes specific disorders in more detail, including Down syndrome, Edward syndrome, Patau syndrome, Turner syndrome, Klinefelter syndrome, Fragile X syndrome, Cri-Du-Chat syndrome, Wolf-Hirschhorn syndrome, Jacobsen syndrome, and Prader-Willi syndrome. It also discusses uniparental disomy and related disorders. In summary, the document defines genetic terminology and provides an overview of several important chromosomal anomalies and their associated genetic disorders
- NUTOGURT is a new frozen yogurt product made from a blend of low-fat yogurt and a milky extract of tigernut tubers. It is designed to be a low-fat alternative to ice cream while providing probiotic benefits.
- Tigernuts are a sedge family crop that are high in energy, minerals, vitamins and fiber. They are commonly used to make a milky beverage in Spain and Nigeria.
- NUTOGURT targets many customer groups due to its expected health benefits such as balancing stress levels, soft skin, improved digestion, reduced risk of colon cancer and heart disease, and being suitable for diabetics, the health conscious, and those with dairy
Este documento presenta el caso de una niña diagnosticada con el Síndrome de Prader-Willi. Incluye un análisis de sus datos personales y médicos significativos, su contexto sociofamiliar y escolar, un análisis curricular de sus fortalezas y necesidades, y un planteamiento para un Plan de Trabajo Individualizado.
The document discusses different topics related to corn production and consumption including:
- Types of corn including open pollinated, hybrid, and genetically modified varieties and the traits they are engineered for like herbicide and insect tolerance.
- A report finding that Monsanto corn causes health issues in mammals.
- Issues around food sovereignty and yields from GM crops.
- Factors contributing to the 2008 food crisis like high oil prices and weather events.
- How corn is used for animal feed, food/seed/industry, and export.
- Impacts of corn ethanol production including high water use and pollution from fertilizers and soil erosion.
- Increasing rates of obesity in Mexico linked to trade liberalization and
Este documento resume una revisión bibliográfica del tratamiento fisioterápico en el síndrome de Prader-Willi. Se discuten varios temas como el tratamiento de la escoliosis, los patrones de marcha, la evaluación de las capacidades específicas y los efectos del ejercicio. Los programas de rehabilitación que incluyen ejercicio físico y dieta han demostrado mejorar la composición corporal, la capacidad física y reducir la ansiedad en pacientes con este síndrome.
Biotechnology applies scientific disciplines including chemistry, engineering, physics and computing to living organisms to create innovative products and techniques. Health biotechnology focuses on creating therapies, drugs, vaccines and diagnostic equipment. Prevnar 13 is a pneumococcal conjugate vaccine that protects against 13 Streptococcus pneumoniae serotypes. It was approved based on clinical trials demonstrating its safety and efficacy in preventing invasive pneumococcal disease.
El documento describe las características clínicas y las bases genéticas y moleculares del síndrome de Angelman y Prader-Willi. El síndrome de Angelman se caracteriza por retraso mental grave, epilepsia severa, risas episódicas y ausencia del lenguaje. El síndrome de Prader-Willi se caracteriza por poco movimiento fetal, hipopigmentación de la piel, hipotonía muscular y problemas alimenticios. Ambos trastornos están asociados con alteraciones en la región 15q11-q13 del cromosoma
El síndrome de Prader-Willi es un trastorno genético raro causado por la falta de uno o más genes en el cromosoma 15 que causa problemas alimenticios, características faciales distintivas y retraso en el desarrollo. Los pacientes con este síndrome experimentan dificultades con el habla y el lenguaje debido a su discapacidad cognitiva y problemas musculares. Requieren terapias de lenguaje y alimentación especializada para mejorar sus habilidades y salud.
This document discusses different methods of blood doping used by athletes to boost oxygen carrying capacity and endurance. It describes how blood doping involves increasing red blood cells through blood transfusions, EPO injections, or blood substitutes. Blood transfusions involve extracting and later reinfusing a person's own red blood cells or receiving another person's blood. EPO injections stimulate the body to produce more red blood cells. Detection methods try to identify abnormal increases in hemoglobin levels that would indicate blood doping. While blood doping can enhance exercise performance, it also carries health risks like heart or lung problems.
Presentation insect resistant transgenic crops ahmad madni (21-12-2016)Ahmed Madni
This document discusses insect-resistant transgenic crops. It begins by defining transgenic crops as crops containing foreign genes that add new traits not found in wild-type crops, such as insect or herbicide resistance. The document then discusses how to develop insect-resistant plant lines through recombinant DNA technology and transformation techniques. As an example, it describes the construction of a plasmid expressing a cry1AC gene to produce Bt corn and cotton that are resistant to certain insects. The document notes both benefits of Bt crops, such as reduced pesticide use and increased yields, and potential risks, including effects on non-target organisms and transfer of transgenes to wild plants.
Modified Atmosphere Packaging
MAP provides extended shelf life for fresh produce by altering the internal atmosphere of packaging to slow respiration and prevent spoilage. Key gases used in MAP include nitrogen, oxygen, and carbon dioxide in varying combinations depending on the food and storage temperature. Innovation in MAP films now includes antioxidant, nano-active, and microperforated films. Future trends point to combining MAP with other preservation technologies, developing films that further inhibit microbial growth and oxidation, and predictive modeling to optimize gas compositions and shelf life.
Prader-Willi Syndrome is a rare genetic disorder that affects 1 in 10,000 people, causing physical and behavioral problems. It is caused by the lack of expression of paternal genes in a specific region of chromosome 15. Symptoms include low muscle tone, incomplete sexual development, cognitive disabilities, problem behaviors, and an insatiable appetite that can lead to obesity. Treatment aims to manage physical symptoms as well as providing behavioral and nutritional therapies.
El síndrome de Prader-Willi es una enfermedad genética rara causada por la ausencia de genes en el cromosoma 15, que causa un apetito insaciable, retraso intelectual y problemas de desarrollo. No tiene cura y se trata sintomáticamente mediante control de peso, dieta, ejercicio y educación especial para controlar el comportamiento.
This document provides an introduction to Bt cotton, including:
- Bt cotton gets its name from the soil-dwelling bacteria Bacillus thuringiensis, which produces Cry proteins that are lethal to certain insect pests when they are eaten.
- Bt cotton is genetically modified to produce these Cry proteins in its tissues in order to reduce losses from attacks by the tobacco budworm and bollworm caterpillar pests.
- The Cry proteins bind to receptors in the guts of susceptible insects and rupture cells, causing the insects to stop feeding and die within 2-3 days after consuming the Bt cotton plants.
El síndrome de Prader-Willi es una enfermedad congénita no hereditaria causada por alteraciones genéticas en el cromosoma 15 que provocan un apetito insaciable y obesidad mórbida. Se presenta en 1 de cada 15.000 nacimientos y sus síntomas incluyen bajo tono muscular, ansiedad por la comida y problemas de comportamiento. No tiene cura pero los tratamientos buscan controlar el peso y mejorar la calidad de vida.
Using food as your medicine discusses how diet impacts cancer risk and progression. It notes that 90-95% of cancer cases are due to environmental and lifestyle factors like diet, smoking, alcohol and obesity. Diet can affect cancer through initiation, promotion and anti-promotion pathways. Carcinogens in foods like red meat and certain fats can initiate cancer, while excess calories, fat, protein and sugars can promote tumor growth. Phytonutrients, antioxidants, fiber and a plant-based diet high in fruits and vegetables can help prevent cancer through anti-promotion effects like detoxification and reducing inflammation. Lifestyle changes including a whole foods, plant-based diet are emphasized as the primary way to take control of cancer risk
This document discusses modified food starches. It begins by explaining that modified starches are normal starches that have been chemically or physically altered. Common modification methods include cross-linking, acid treatment, and oxidation. Modified food starches are used as thickeners, emulsifiers, and stabilizers in foods. They allow foods to have longer shelf lives and help bind ingredients. Some common foods containing modified starches include canned soups, chips, and cheese sauces. The document also discusses retrogradation, which is the process by which starch molecules realign and recrystallize.
This document provides an overview of Prader-Willi Syndrome (PWS), including:
1. PWS is caused by abnormalities on chromosome 15 that result in problems with feeding, motor skills, cognition and behavior as well as obesity.
2. Clinical features include neonatal hypotonia, poor feeding, developmental delays, hyperphagia leading to obesity, and characteristic facial features.
3. Diagnosis involves genetic testing to identify deletions, disomy or mutations on chromosome 15; treatment aims to manage feeding, obesity, endocrine issues, and behavioral challenges through a multidisciplinary approach.
This document provides information on various human genetic disorders including their symptoms, causes, populations affected, and available treatments. Some of the genetic disorders discussed include Down syndrome, sickle cell anemia, cystic fibrosis, phenylketonuria, albinism, Marfan syndrome, Klinefelter syndrome, and Turner syndrome. The causes include chromosomal abnormalities, single gene mutations, and multifactorial inheritance patterns. Treatments range from managing symptoms to dietary modifications to gene or stem cell therapies.
This document provides an overview of Down syndrome including definitions, features in newborns, common abnormalities, and age-specific healthcare guidelines. It summarizes the incidence of Down syndrome as occurring in 1 in 660 newborns. Common physical features in newborns include slanted palpebral fissures, anomalous auricles, and hypotonia. The document outlines numerous potential abnormalities and provides healthcare guidelines for individuals with Down syndrome from the neonatal period through adulthood.
Schizophrenia is a severe mental disorder that causes symptoms such as hallucinations, delusions and disorganized thinking. It affects about 1% of the population and typically emerges during late adolescence or early adulthood. The exact causes are unknown but likely involve a combination of genetic and environmental factors. Diagnosis is based on symptoms and management involves antipsychotic medications and psychosocial therapies. Prognosis varies but many people are able to lead relatively normal lives with proper long-term treatment and support.
This document discusses the evaluation of short stature in children. It begins by outlining the relevant history to obtain, including perinatal history, family history, past medical history, and systemic reviews. The physical examination focuses on assessing proportionate versus disproportionate short stature and examining for dysmorphic features or other abnormalities. Investigations outlined include bone age, hormonal assays, karyotyping, and tests to investigate for underlying chronic illnesses. Treatment involves treating any identified cause, such as growth hormone deficiency, as well as supportive measures like nutrition, vitamins, and psychological support.
Recent studies both community and hospital based have shown that there is a significant burden of psychiatric disorder in epilepsy, with as many as 50% of all subjects studied being affected.
The available epidemiological data suggests that psychiatric disorders are over-represented in epilepsy, the evidence for psychosis in particular being rather compelling
This document provides information on autism spectrum disorders including:
- A brief history noting early descriptions by Kanner and Maudsley.
- Epidemiology showing prevalence of 2 per 1000, higher rates in males, and associations with intellectual disability.
- Etiology discussing theories including genetic, neurological, immunological and perinatal factors.
- Clinical features such as impairments in social skills, communication deficits, stereotyped behaviors and sensory issues.
- Diagnostic classifications including autism, Asperger's syndrome, and other conditions under the pervasive developmental disorder umbrella.
This child presents with drooping eyelids and squint that worsens in the evenings.
- Myasthenia gravis.
- Ask about weakness of other muscles, response to rest.
- Tensilon test and acetylcholine receptor antibody levels would help confirm the diagnosis.
This document presents a case study of 16-year-old Soumya who was brought to the hospital with fever, shortness of breath, and vomiting. After examination, she was diagnosed with progeria. Progeria is an extremely rare genetic condition where children exhibit rapid aging symptoms. It is caused by a genetic mutation that prevents prelamin A from being properly processed. Children with progeria have short stature, loss of hair and body fat, stiff joints, heart disease, and typically die in their early teens. While currently incurable, research is ongoing to develop treatments to target the underlying genetic cause.
Schizophrenia is a serious mental illness that affects how a person thinks, f...AmitSherawat2
Schizophrenia is a serious mental illness that affects how a person thinks, feels, and behaves. People with schizophrenia may seem like they have lost touch with reality, which can be distressing for them and for their family a
The document discusses depression and insomnia, including their epidemiology, assessment, and evidence-based treatments. It notes that depression affects over 350 million people globally and is a leading cause of disability. Common treatments include cognitive behavioral therapy, behavioral activation, mindfulness-based therapies, and various medications. Insomnia impacts up to 35% of some populations and is associated with health risks. Evaluation of insomnia involves assessing sleep patterns and behaviors, while treatments focus on improving sleep hygiene, relaxation, and stimulus control.
This document provides an overview of several human genetic disorders, including descriptions of their symptoms and inheritance patterns. Autosomal recessive disorders discussed include cystic fibrosis, galactosemia, and phenylketonuria. Autosomal dominant disorders include breast cancer, colon cancer, and Huntington's disease. Nondisjunction disorders cause aneuploidy and include Down syndrome, Patau syndrome, and Edwards syndrome. Other sections cover sex-linked disorders like Turner syndrome and Klinefelter syndrome, as well as fragile X syndrome, metabolic disorders, teratogens, genomic imprinting disorders like Prader-Willi and Angelman's syndromes, and rare conditions such as progeria. Throughout, the document provides statistics
This document provides an overview of genetic counseling. It defines genetics and genetic counseling, lists their objectives and components. It describes pedigree charting and the roles of the genetic counselor in providing information, estimating risk, and transmitting information to clients. Examples are given of different inheritance patterns and genetic disorders. The role of nurses in genetic counseling is outlined as receiving clients, obtaining family histories, providing support and information, encouraging questions, and maintaining privacy.
This document provides information about mental retardation, including its definition, degrees of severity, epidemiology, etiology, diagnosis, management, and case study. It defines mental retardation as significantly below average intellectual functioning and impaired adaptive behavior that manifests before age 18. It describes the mild, moderate, severe and profound degrees and their characteristics. Causes include genetic and environmental factors. Diagnosis involves history, examination, psychological assessment and lab tests. Management includes education, therapy and social support services tailored to the individual's needs. A case study example is also included.
1. Genetics plays an important role in understanding human health and disease by studying the interaction between genetic and environmental factors.
2. Chromosomes contain DNA and genes which code for proteins. Any changes or mutations in genes and chromosomes can alter the proteins produced and lead to genetic disorders.
3. Important genetic disorders discussed include Down syndrome, sickle cell anemia, cystic fibrosis, hemophilia, and phenylketonuria. Multifactorial diseases like diabetes and heart disease are influenced by multiple genes and environmental exposures.
4. Advances like gene therapy, the human genome project, and prenatal screening provide opportunities for prevention and treatment of genetic conditions. Genetic counseling educates families on inheritance patterns
Human genetics and heredity can now be studied with greater understanding thanks to advances like the Human Genome Project. The project mapped all human DNA which contains around 31,000 genes packed into the 46 chromosomes in every human cell. This has led to insights into inherited traits and diseases, new genetic tests, and holds promise for gene therapy to treat conditions. However, the power of genetic knowledge also raises ethical issues society must address around manipulating the human genome.
- Child psychiatry deals with psychiatric disorders that are relatively specific to children and adolescents, arising during development. These include intellectual disabilities, learning disorders, autism spectrum disorders, attention deficit hyperactivity disorder, and other conditions.
- Assessing children requires developmentally appropriate evaluations that involve families and others, using concrete language and observation. Diagnoses involve psychological testing and consider developmental norms.
- Common childhood conditions addressed in child psychiatry include intellectual disabilities, learning disorders, autism, ADHD and other neurodevelopmental and behavioral disorders. Treatment involves educational and behavioral interventions along with treating any comorbidities.
The document provides information about Huntington's disease (HD), including:
1) HD is a hereditary neurodegenerative disorder caused by a CAG repeat expansion in the HD gene, and is characterized by motor, cognitive, and psychiatric symptoms.
2) The disease primarily involves degeneration of the basal ganglia, especially the caudate and putamen nuclei.
3) Symptoms typically begin in mid-life and include chorea, dystonia, cognitive impairment, and psychiatric issues. There is currently no cure for HD.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
3. Brief introduction
• Rare
• Developmental disability
• 15th chromosome
• hypothalamus doesn't work
properly
• Key feature: hunger games.
• Not INHERITED disease
– Only 1%
4. Genetics
• Lack of 7 active genes on chromosome 15
• (15q11-q13)
• Genes normally active on paternal
chromosome.
5. • 70%
• Paternal 15, PWS region deleted/missing
Paternal deletion
• 25%-28%
• Both copies from mother
Maternal
uniparental
disomy
• 2%
• Genes are present but do not work.
• Inherited
Imprinting defect
6.
7. History
• 1956
• Andrea Prader, Heinrich Willi, Alexis Labhart.
• Also called: Prader Labhart Willi syndrome.
8. Prevalence
• 1 in 10,000 to 30,000 people worldwide.
• Not racial- both sexes
9. Characteristics
• Dysfunction of hypothalamus
• Responsible for functions like:
– Hunger, temperature and pain regulation, puberty,
emotions, and fertility.
• Unclear how genetic abnormality leads to
hypothalamic dysfunction.
10. Symptoms
First stage (hypotonia)
Hypotonic , low muscle
tone.
Weak cry and a poor suck
reflex are typical.
Low levels of GH
Physical abnormalities:
narrow forehead,
almond-shaped eyes,
triangular mouth,
short stature,
small hands and feet
Second stage (hyperphagia)
An unregulated appetite.
Most common 2-6 years.
Individuals with PWS lack
normal hunger and satiety
cues.
M.R of persons with PWS is
lower than normal.
Leads to morbid obesity
Low sex hormone levels
(hypogonadism)
11.
12. More symptoms
o Behavioral problems, such as stubbornness or temper
tantrums
o Delayed motor skills and speech, not sporty.
o Cognitive problems, ranging from near normal intelligence to
mild mental retardation; learning disabilities are common
o Repetitive thoughts and verbalizations
o Collecting and hoarding of possession.
13. Facts
• It is a SPECTRUM DISORDER
• Mental strengths
• Normal lifespan
• Diabetes and Obsessive Compulsive Disorder
• Depression is common
14. Diagnosis
• FISH (fluorescence in situ hybridization)
Specific DNA sequences on chromosomes.
High degree of sequence similarity.
Fluorescence microscopy can be used to find out where the fluorescent probe
bound to the chromosomes.
FISH is often used for finding specific features in DNA for use in genetic counseling,
medicine, and species identification.
FISH can also be used to detect and localize specific mRNAs within tissue samples.
In this context, it can help define the spatial-temporal patterns of gene expression
within cells and tissues.
18. Hope for the future
• More research
• Focus on obesity
• Hope today- for a cure tomorrow
Editor's Notes
PWS is caused by a lack of active genetic material in a particular region of chromosome 15 (15q11-q13). Or fail to inherit genes in the critical region Normally, individuals inherit one copy of chromosome 15 from their mother and one from their father. The genes in the PWS region are normally only active on the chromosome that came from the father. In PWS, the genetic defect causing the inactivity of chromosome 15 from the father (paternal chromosome 15) can occur in one of three ways:
Approximately 70% cases. Most common.
Part of chromosome 15 inherited from child’s father – PWS critical gene area – is missing/deleted
Baby inherits both copies of chromosomes 15 from on parent – the mother.
Maternal = mother
Uniparental = 1 parent
Disomy = 2 chromosomes
Due to dna methylation or translocation or mutation. 1% chance of inheriting the defective chromosome 15 from father.
Prader-Willi syndrome affects an estimated 1 in 10,000 to 30,000 people worldwide.
Symptoms are believed to be caused by dysfunction of a portion of the brain called the hypothalamus.
The hypothalamus is a small endocrine organ at the base of the brain that plays a crucial role in many bodily functions like, hunger and satiety, temperature and pain regulation, fluid balance, puberty, emotions, and fertility.
Although hypothalamic dysfunction is believed to lead to the symptoms of PWS, it is unclear how the genetic abnormality causes hypothalamic dysfunction.
Stage 1
In the first stage, infants with PWS are hypotonic or "floppy", with very low muscle tone.
Weak cry and a poor suck reflex are typical. Babies with PWS usually are unable to breastfeed and frequently require tube feeding.
These infants may suffer from "failure to thrive" if feeding difficulties are not carefully monitored and treated.
As these children grow older, strength and muscle tone generally improve.
Motor milestones are achieved, but are usually delayed.
Stage 2:
An unregulated appetite characterizes the second stage of PWS.
This stage most commonly begins between ages 2 and 6 years old.
Individuals with PWS lack normal hunger and satiety cues.
They usually are not able to control their food intake and will overeat if not closely monitored.
Food seeking behaviors are very common.
In addition, the metabolic rate of persons with PWS is lower than normal.
Left untreated, the combination of these problems will lead to morbid obesity and its many complications.
Behavioral problems, usually during transitions and unanticipated changes, such as stubbornness or temper tantrums
Delayed motor skills and speech due to low muscle tone
Cognitive problems, ranging from near normal intelligence to mild mental retardation; learning disabilities are common
Repetitive thoughts and verbalizations
Collecting and hoarding of possessions
Picking at skin
Low sex hormone levels sex organs never develop fully and males and females are both sterile
Prader-Willi syndrome is considered a spectrum disorder, meaning not all symptoms will occur in everyone affected and the symptoms may range from mild to severe.
People with Prader-Willi often have some mental strengths as well, such as skills in jigsaw puzzles.
If obesity is prevented, people with the syndrome can live a normal lifespan.
PRADER WILLI often times results in diabetes and Obsessive Compulsive Disorder
his test may also be called Southern Hybridization Methylation Specific PCR Assay or Methylation Specific PCR Test. The key word is "Methylation" and it is the most sensitive diagnostic test for Angelman Syndrome. This test will positively identify about 80% of individuals with Angelman Syndrome. Methylation refers to a chemical "tag" added to DNA and can be used to identify whether the DNA was contributed by the mother or the father. Where this tag is added occurs in a distinct pattern if it came from the mother and a different distinct pattern if it came from the father. The pattern of this tag can be examined to determine which parent contributed the DNA. The DNA methylation test will determine if an individual has one of each pattern (one from each parent) or an Angelman Syndrome pattern (where only the pattern from the father is present.) Using our encyclopedia analogy, DNA is like the pages inside the encyclopedia volumes. The methylation test is like opening the two "volumes" of chromosome 15 and looking up the page of the specific "chapter" contributed by each parent to see which parent's pattern is visible on the page. In the methylation test, these individuals will show only the methylation pattern from the mother and are missing the pattern from the father.
No cure. But there are ways to improve the qualitry of life of prader willi suffereres
In multiple studies, human growth hormone (HGH) has been found to be beneficial in treating Prader-Willi syndrome.
In June of 2000, HGH was officially recognized by the Federal Drug Administration (FDA) in the United States and other countries for use in patients with Prader-Willi syndrome.
HGH is effective not only in increasing height, but also
Decreasing body fat, increasing muscle mass
Improving weight distribution
Increasing stamina,
Increasing bone mineral density
Physical therapy. Muscle weakness is a serious problem among individuals with PWS. For children younger than age 3, physical therapy may increase muscular strength and help such children achieve developmental milestones. For older children, daily exercise will help build lean body mass.
Behavioral therapy. People with PWS have difficulty controlling their emotions. Using behavioral therapy can help. Stubbornness, anger, and obsessive-compulsive behavior, including obsession with food, should be handled with behavioral management programs using firm limit-setting strategies. Structure and routines also are advised.1,5
Medications.Medications, especially serotonin reuptake inhibitors (SRIs), may reduce obsessive-compulsive symptoms. SRIs also may help manage psychosis.
Sex hormone treatments and/or corrective surgery.These treatments are used to treat small genitals (penis, scrotum, clitoris).
Restricted access to food and strict supervision of food intake may be required.